Johnson & Johnson Canada
在场
Johnson & Johnson Canada 的所有者是 Johnson & Johnson.
是其中之一......
- Forbes Global 2000 (#45);
- Fortune 500 (#42);
- Global Fortune 500 (#115);
- Russell 3000;
- S&P 500;
- TOB Iconic 10,000.
Johnson & Johnson 是一家在股票代码 JNJ (US) 下上市的公司。
Johnson & Johnson 在 23 个国家有直接业务。Johnson & Johnson 拥有 65家子公司，其中包括 Abiomed、Ambrx 和 DePuy Synthes。
他们在：
涉及Johnson & Johnson的并购和融资。
- Johnson & Johnson 已收购 V-Wave (公布2024十月9号).
- Johnson & Johnson has announced the acquisition of Proteologix (公布2024六月21号).
- Johnson & Johnson has announced the acquisition of Proteologix (公布2024五月20号).
- Johnson & Johnson has announced the acquisition of Shockwave Medical (公布2024四月6号).
- Johnson & Johnson 已收购 Ambrx (公布2024一月11号).
- 查看更多"Johnson & Johnson"相关新闻 Hide news involving Johnson & Johnson
高管
查看带有其 2 名主要高管的组织结构图
Johnson & Johnson Canada 搜索最多的简介
- Andy Williams, Vice President, Sales & Marketing
- Anna Caravaggio, Vice President, Global Health Equity Access & Pro...
高管在Johnson & Johnson变化
- Scott Davis, Director, 正在办理退休 (新闻发布的2024九月11号).
- Kristen Mulholland 曾任 Head of Human Resources, Global Total Rewards, 将于 202410月1 升职为 Chief Human Resources Officer (新闻发布的2024八月26号).
- Peter Fasolo, Executive Vice President and Chief Human Resources Officer, 将于 202410月1 退休 (新闻发布的2024八月26号).
创建提醒
跟踪 Johnson & Johnson Canada 的高管变动
药店
Johnson & Johnson 拥有 1,840 家竞争者，其中包括 Pfizer (美国(美洲))、Sanofi (法国) 和 Roche (瑞士)。
Popular M&A news in 药店
- Recursion Pharma and Exscientia have merged (公布2024十一月27号)..
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
- BeiGene将改名为BeOne Medicines。 (公布2024十一月15号).
药店 行业的其他推荐联系人
消息
Johnson & Johnson Canada 的最新新闻稿
- What You Need to Know About Johnson & Johnson's 2023 Second-Quarter Earnings
- Johnson & Johnson Releases its 2022 Health for Humanity Report and We All Belong: 2022 DEI Impact Review
- What You Need to Know About Johnson & Johnson's 2023 First-Quarter Earnings
- Johnson & Johnson Named to Fortune's 2023 America's Most Innovative Companies List
- LinkedIn Login, Sign in | LinkedIn
- Microbiome Researcher Jeffrey Gordon Receives the 2022 Dr. Paul Janssen Award for Biomedical Research
- Johnson & Johnson Named a 2023 Fortune World’s Most Admired Company and Ranked #1 on the Pharmaceutical Industry List
- Media Center Archive | Johnson & Johnson
- What You Need to Know About Johnson & Johnson's 2022 Fourth-Quarter and Full-Year Earnings Report
- View more press releases Close
通过电子邮件
